Metformin HydrochlorideMeSH concept

https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-accord
2022
false
false
false
Netherlands
French
English
drugs, generic
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
metformin and sitagliptin
hypoglycemic agents
incretins
dipeptidyl-peptidase iv inhibitors
drug combinations
metformin
Metformin Hydrochloride
sitagliptin
diabetes mellitus, type 2
drug approval
europe

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vildagliptin-metformin-hydrochloride-accord
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Vildagliptin
Vildagliptin
drug combinations
Metformin Hydrochloride
Metformin Hydrochloride
metformin and vildagliptin
drugs, generic

---
https://www.has-sante.fr/jcms/p_3317079/fr/glimezit-metformine
2022
false
false
false
France
Metformin Hydrochloride
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
hypoglycemic agents
administration, oral
metformin
adult
child
adolescent
drugs, generic
evaluation of the transparency committee
metformin

---
https://www.has-sante.fr/jcms/p_3376996/fr/sitagliptine/metformine-alter-sitagliptine-/-metformine
2022
false
false
false
France
adult
diabetes mellitus, type 2
treatment outcome
insurance, health, reimbursement
drug combinations
sitagliptin
metformin
administration, oral
hypoglycemic agents
metformin and sitagliptin
Product containing only metformin and sitagliptin in oral dose form (medicinal product form)
dipeptidyl-peptidase iv inhibitors
Metformin Hydrochloride
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3283458/fr/jentadueto-linagliptine/-metformine
2021
false
false
false
France
evaluation of the transparency committee
Metformin Hydrochloride
metformin
drug combinations
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
administration, oral
Linagliptin
metformin and linagliptin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
Product containing only linagliptin and metformin in oral dose form (medicinal product form)
incretins
jentadueto

---
https://www.has-sante.fr/jcms/p_3284684/fr/eucreas-50-mg/1000-mg-vildagliptine-/-metformine
2021
false
false
false
France
hypoglycemic agents
Metformin Hydrochloride
drug combinations
Vildagliptin
dipeptidyl-peptidase iv inhibitors
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
evaluation of the transparency committee
metformin
administration, oral
treatment outcome

---
https://www.has-sante.fr/jcms/p_3218341/fr/synjardy
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
metformin
Metformin Hydrochloride
empagliflozin
metformin and empagliflozin
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
administration, oral
diabetes mellitus, type 2
guidelines for drug use
evaluation of the transparency committee
benzhydryl compounds
glucosides

---
https://www.has-sante.fr/jcms/p_3224069/fr/eucreas
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
administration, oral
Vildagliptin
Metformin Hydrochloride
metformin and vildagliptin
diabetes mellitus, type 2
hypoglycemic agents
metformin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/qtrilmet
2019
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
metformin
dapagliflozin
saxagliptin
Metformin Hydrochloride
Metformin Hydrochloride
hypoglycemic agents
hypoglycemic agents
drug approval
europe
metformin, saxagliptin and dapagliflozin
diabetes mellitus, type 2
adult
administration, oral
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Glycated Hemoglobin
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dapagliflozin
metformin
dapagliflozin
saxagliptin
dapagliflozin
dipeptides
adamantane
glucosides
benzhydryl compounds
dapagliflozin
dipeptides
glucosides
benzhydryl compounds

---
Segluromet ertugliflozin / metformin hydrochloride
https://www.ema.europa.eu/medicines/human/EPAR/Segluromet
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
metformin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
Metformin Hydrochloride
Metformin Hydrochloride
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
metformin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---